£33.00£300.00

Tofisopam 100mg is an Etizolam substitute.

They are an benzodiazepine analogue from a class of drugs known as thienodiazepines and, like most drugs similar to benzodiazepines, it has amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and muscle-relaxing properties.

What is Tofisopam 100mg?

Tofisopam 100 Tablet belongs to a class of medicines called benzodiazepines. It is used in the treatment of depression and anxiety associated with depression. It has a calming effect on the brain by relaxing the nerves, thus relieving the symptoms of anxiety.

This tablet may be taken with or without food. However, take it at the same time each day as this helps to maintain a consistent level of medicine in the body. Take this medicine in the dose and duration as advised by your doctor as it has a high potential of habit-forming.

If you have missed a dose, take it as soon as you remember and finish the full course of treatment even if you feel better. It is important that this medication is not stopped suddenly without talking to your doctor as it may cause nausea and anxiety. It should only be used for a limited period as long-term use of this medicine is not recommended.

Tofisopam 100 Tablet may cause loss of appetite, nausea, dry mouth, headaches, insomnia, and constipation. These are usually temporary and resolve on their own. Consult your doctor if these side effects bother you or do not go away. Do not operate heavy machinery or drive if you have taken this medicine until you know how it affects your body.

It should be noted that in elderly patients this medicine may reduce muscle tone and increased the risk of falls. You should avoid alcohol intake while taking this medicine as it will increase drowsiness. Please inform your doctor if you are pregnant, planning to conceive or breastfeeding, before taking this medicine.

Tofisopam (Tofisign) 100mg
Tofisopam (Tofisign) 100mg
SKU: Tofisopam100 Category:
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.